Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Psychedelics as Medicine? A Look at Alternative Treatments for Mental Health Conditions
Are psychedelics the next “miracle” drug to treat mental health conditions?
Auto Casualty
Article
Data Analytics in Insurance Claims Processing: Trends & Benefits
Whether it is boosting claim process efficiency or increasing consistency, claims organizations are turning to data analytics in insurance claim pr
Mitchell
Article
Workers' Comp 2021 Technology Trends Report
One year after the start of the COVID-19 pandemic, we wanted to know: How has technology use changed over the past year in the workers’ compensatio
Workers' Comp
Virtual Event
Webinar: The Whole Person Approach
On-Demand
Identifying social determinants of health to assist in recovery and return to work Case managers have long known the importance of gettin
Mitchell
Virtual Event
Coventry Webinar: Long COVID and the Enduring Challenges for Workers
On-Demand
Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and
Mitchell
News Release
ODG Updates Muscle Relaxant Formulary
On March 31, 2021, the Official Disability Guidelines (ODG by MCG) announced changes to the